Digital therapeutic company Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines.The de novo classification is for the company’s CT-132 offering, which it received…
Continue Reading
Breakthrough Cancer Treatment Receives IDE Approval
Alpha Tau Medical Ltd. has achieved a significant milestone in cancer treatment innovation. The FDA has granted an Investigational Device Exemption (IDE) for a pilot study using their revolutionary…
During a town hall in Wisconsin streamed live on YouTube on Monday, Elon Musk announced his brain-computer interface implant startup Neuralink will perform its first human implant of Blindsight, aimed at restoring vision in…
Continue Reading
Wysa, a company offering an AI-enabled mental health chatbot, announced it is merging with April Health, which integrates virtual behavioral health services into primary care. Wysa’s chatbot guides users through cognitive behavioral therapy for concerns…
Continue Reading
Women’s Health company Teal Health announced it garnered an additional $10 million in seed funding to support the launch of the Teal Wand, an at-home self-collect cervical cancer screening device, which is currently under…
Continue Reading
Welcome to the September edition of Digital Health Digest! This month, we cover groundbreaking developments, from Particle Health’s legal battle against Epic to hologram doctor visits at West Cancer Center and Neuralink’s latest FDA…
Continue Reading
Qure.ai nets $65M for foundational AI Qure.ai has raised $65 million in a Series D funding round led by Lightspeed and 360 ONE Asset.
The company said it will use its fresh funds to invest more in foundational…
Elon Musk’s brain-computer interface implant startup Neuralink has received FDA breakthrough device designation for Blindsight, an implant that aims to restore vision in individuals who are blind.Blindsight implants a microelectrode array into the visual…
Continue Reading
What You Should Know:
– ALZpath, a leader in Alzheimer’s disease diagnostics, announced a licensing agreement with Roche for their innovative pTau217 antibody. This paves the way for a blood test to diagnose Alzheimer’s disease…
Continue Reading
South Korea OKs new stroke prediction AI softwareSouth Korea’s Ministry of Food and Drug Safety has recently approved an AI-based software for predicting the onset of ischemic stroke or cerebral infarction.
The NNS-SOT software, developed…
